Fibrosis Progression and the Pros and Cons of Antiviral Therapy for Hepatitis C Virus Recurrence After Liver Transplantation: A Review
β Scribed by E. De Martin; M. Senzolo; M. Gambato; G. Germani; A. Vitale; F.R. Russo; P. Burra
- Book ID
- 116936315
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 103 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Significant liver fibrosis (F >or= 2) and portal hypertension (hepatic venous pressure gradient [HVPG] >or= 6 mmHg) at 1 year after liver transplantation (LT) identify patients with severe hepatitis C recurrence. We evaluated whether repeated liver stiffness measurements (LSM) following LT can discr
Allograft gene expression analysis may provide insights into the mechanisms involved in liver damage during hepatitis C virus recurrence (HCVrec) after orthotopic liver transplantation (OLT) and allow the identification of patients who have a higher risk of developing severe disease. Forty-three OLT